» Articles » PMID: 38001092

In Vivo Imaging of Mitochondrial DNA Mutations Using an Integrated Nano Cas12a Sensor

Overview
Journal Nat Commun
Specialty Biology
Date 2023 Nov 24
PMID 38001092
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in mitochondrial DNA (mtDNA) play critical roles in many human diseases. In vivo visualization of cells bearing mtDNA mutations is important for resolving the complexity of these diseases, which remains challenging. Here we develop an integrated nano Cas12a sensor (InCasor) and show its utility for efficient imaging of mtDNA mutations in live cells and tumor-bearing mouse models. We co-deliver Cas12a/crRNA, fluorophore-quencher reporters and Mg into mitochondria. This process enables the activation of Cas12a's trans-cleavage by targeting mtDNA, which efficiently cleave reporters to generate fluorescent signals for robustly sensing and reporting single-nucleotide variations (SNVs) in cells. Since engineered crRNA significantly increase Cas12a's sensitivity to mismatches in mtDNA, we can identify tumor tissue and metastases by visualizing cells with mutant mtDNAs in vivo using InCasor. This CRISPR imaging nanoprobe holds potential for applications in mtDNA mutation-related basic research, diagnostics and gene therapies.

Citing Articles

Functional Nucleic Acid Nanostructures for Mitochondrial Targeting: The Basis of Customized Treatment Strategies.

He W, Dong S, Zeng Q Molecules. 2025; 30(5).

PMID: 40076250 PMC: 11902231. DOI: 10.3390/molecules30051025.


The Matrix of Mitochondrial Imaging: Exploring Spatial Dimensions.

Hemel I, Arts I, Moerel M, Gerards M Biomolecules. 2025; 15(2).

PMID: 40001532 PMC: 11853629. DOI: 10.3390/biom15020229.


CRISPR in clinical diagnostics: bridging the gap between research and practice.

Lafi Z, Ata T, Asha S Bioanalysis. 2025; 17(4):281-290.

PMID: 39902531 PMC: 11866644. DOI: 10.1080/17576180.2025.2459520.


Topologically constrained DNA-mediated one-pot CRISPR assay for rapid detection of viral RNA with single nucleotide resolution.

Li Y, Xu R, Quan F, Wu Y, Wu Y, Zhang Y EBioMedicine. 2025; 112:105564.

PMID: 39862805 PMC: 11873568. DOI: 10.1016/j.ebiom.2025.105564.


Amplification-free miRNA detection with CRISPR/Cas12a system based on fragment complementary activation strategy.

Zhao S, Zhang Q, Luo R, Sun J, Zhu C, Zhou D Chem Sci. 2024; .

PMID: 39449688 PMC: 11495492. DOI: 10.1039/d4sc05647g.


References
1.
Kim E, Agarwal S, Kim N, Hage F, Leonardo V, Gelmi A . Bioinspired Fabrication of DNA-Inorganic Hybrid Composites Using Synthetic DNA. ACS Nano. 2019; 13(3):2888-2900. PMC: 6439439. DOI: 10.1021/acsnano.8b06492. View

2.
Bi R, Li Y, Xu M, Zheng Q, Zhang D, Li X . Direct evidence of CRISPR-Cas9-mediated mitochondrial genome editing. Innovation (Camb). 2022; 3(6):100329. PMC: 9579715. DOI: 10.1016/j.xinn.2022.100329. View

3.
Daw C, Ramachandran K, Enslow B, Maity S, Bursic B, Novello M . Lactate Elicits ER-Mitochondrial Mg Dynamics to Integrate Cellular Metabolism. Cell. 2020; 183(2):474-489.e17. PMC: 7572828. DOI: 10.1016/j.cell.2020.08.049. View

4.
Momcilovic M, Jones A, Bailey S, Waldmann C, Li R, Lee J . In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer. Nature. 2019; 575(7782):380-384. PMC: 7328016. DOI: 10.1038/s41586-019-1715-0. View

5.
Taylor R, Turnbull D . Mitochondrial DNA mutations in human disease. Nat Rev Genet. 2005; 6(5):389-402. PMC: 1762815. DOI: 10.1038/nrg1606. View